Development of an ELISA using recombinant Dengue NS1 constructs to measure antibody titers and predict dengue disease outcome in a pediatric population in India | Synapse
March 3, 2026
Development of an ELISA using recombinant Dengue NS1 constructs to measure antibody titers and predict dengue disease outcome in a pediatric population in India
Key Points
Dengue antibody titers can effectively predict disease outcomes in affected children, indicating the study's relevance.
Key evidence reveals a strong correlation between antibody levels and disease severity, with implications for early intervention.
This involves an ELISA using recombinant Dengue NS1 constructs to assess antibody titers in children diagnosed with dengue.
Findings may enable improved clinical strategies for managing dengue risks in pediatric care settings.